{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T14:20:50Z","timestamp":1758637250473},"reference-count":18,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2015,8,25]],"date-time":"2015-08-25T00:00:00Z","timestamp":1440460800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"DOI":"10.1371\/journal.pntd.0003983","type":"journal-article","created":{"date-parts":[[2015,8,25]],"date-time":"2015-08-25T14:19:22Z","timestamp":1440512362000},"page":"e0003983","update-policy":"http:\/\/dx.doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":2,"title":["Case Report: No Response to Liposomal Daunorubicin in a Patient with Drug-Resistant HIV-Associated Visceral Leishmaniasis"],"prefix":"10.1371","volume":"9","author":[{"given":"Nicholas J.","family":"Gow","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert N.","family":"Davidson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rob","family":"Ticehurst","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Burns","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark G.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2015,8,25]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1128\/CMR.00061-07","article-title":"The relationship between leishmaniasis and AIDS: the second 10 years","volume":"21","author":"J Alvar","year":"2008","journal-title":"Clin Micro Rev"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"e2869","DOI":"10.1371\/journal.pntd.0002869","article-title":"Visceral leishmaniasis and HIV coinfection in East Africa","volume":"8","author":"E Diro","year":"2014","journal-title":"PLOS Negl Trop Dis"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1097\/00005792-200101000-00006","article-title":"Visceral leishmaniasis in Human Immunodeficiency Virus (HIV)-infected and non-HIV-infected patients","volume":"80","author":"V Pintado","year":"2001","journal-title":"Medicine"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"e2195","DOI":"10.1371\/journal.pntd.0002195","article-title":"Efficacy of anti-leishmania therapy in visceral leishmaniasis among HIV infected patients: A systematic review with indirect comparison","volume":"7","author":"GF Cota","year":"2013","journal-title":"PLoS Negl Trop Dis"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/QCO.0b013e32835c2198","article-title":"Clinical aspects of visceral leishmaniasis in HIV infection","volume":"26","author":"JN Jarvis","year":"2013","journal-title":"Curr Opin Infect Dis"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"350","DOI":"10.2307\/3283487","article-title":"Potential of doxorubicin as an antileishmanial agent","volume":"78","author":"R Sett","year":"1992","journal-title":"J Parasitol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"2650","DOI":"10.1093\/jac\/dks286","article-title":"Development of nanocapsules bearing doxorubicin for macrophage targeting through the phosphatidylserine ligand: a system for intervention in visceral leishmaniasis","volume":"67","author":"S Kansal","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/978-0-387-77570-8_9","article-title":"DNA topoisomerases of Leishmania: the potential targets for anti-leishmanial therapy","volume":"625","author":"BB Das","year":"2008","journal-title":"Adv Exp Med Biol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1086\/382048","article-title":"Targeting of parasite-specific immunoliposome-encapsulated doxorubicin in the treatment of experimental visceral leishmaniasis","volume":"189","author":"S Mukherjee","year":"2004","journal-title":"J Infect Dis"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1200\/JCO.1996.14.8.2353","article-title":"Randomized phase III trial of liposomal daunorubicin versus doxorubicin, bleomycin, and vincristine in AIDS-related Kaposi\u2019s sarcoma","volume":"14","author":"PS Gill","year":"1996","journal-title":"J Clin Oncol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s002800051025","article-title":"The pharmacokinetics of liposomal encapsulated daunorubicin are not modified by HAART in patients with HIV-associated Kaposi\u2019s sarcoma","volume":"45","author":"L Fumagalli","year":"2000","journal-title":"Cancer Chemother Pharmacol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"441","DOI":"10.3109\/02652048.2012.752532","article-title":"Development of doxorubicin loaded novel core shell structured nanocapsules for the intervention of visceral leishmaniasis","volume":"30","author":"S Kansal","year":"2013","journal-title":"J Microencapsul"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1093\/infdis\/jit547","article-title":"Macrophages accumulate in the gut mucosa of untreated HIV-infected patients","volume":"209","author":"K Allers","year":"2014","journal-title":"J Infect Dis"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"5542","DOI":"10.4049\/jimmunol.1301810","article-title":"Programmed death 1-mediated T cell exhaustion during visceral leishmaniasis impairs phagocyte function","volume":"191","author":"KJ Esch","year":"2013","journal-title":"J Immunol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1007\/s00280-004-0825-y","article-title":"Pharmacokinetics of liposomal doxorubicin (TLC-D99; Myocet) in patients with solid tumors: an open-label, single-dose study","volume":"54","author":"K Mross","year":"2004","journal-title":"Cancer Chemother Pharmacol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"2855","DOI":"10.1128\/MCB.12.6.2855","article-title":"Multidrug resistance in Leishmania donovani is conferred by amplification of a gene homologous to the mammalian mdr1 gene","volume":"12","author":"DM Henderson","year":"1992","journal-title":"Mol Cell Biol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.1128\/AAC.45.9.2468-2474.2001","article-title":"Alkyl-lysophospholipid resistance in multi-drug-resistant <italic>Leishmania tropica<\/italic> and chemosensitization by a novel P-glycoprotein-like transporter modulator","volume":"45","author":"JM Perez-Victoria","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"69","DOI":"10.4103\/2229-5070.145594","article-title":"Hypothesis: the potential application of doxorubicin against cutaneous leishmaniasis","volume":"5","author":"M Keighobadi","year":"2015","journal-title":"Trop Parasitol"}],"container-title":["PLOS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pntd.0003983","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,22]],"date-time":"2018-10-22T20:02:58Z","timestamp":1540238578000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0003983"}},"subtitle":[],"editor":[{"given":"Carlos","family":"Franco-Paredes","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2015,8,25]]},"references-count":18,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2015,8,25]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0003983","relation":{},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,8,25]]}}}